Found: 26
Select item for more details and to access through your institution.
Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
- Published in:
- 2019
- By:
- Publication type:
- journal article
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep04874
- By:
- Publication type:
- Article
c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 24, p. 3972, doi. 10.3390/cells11243972
- By:
- Publication type:
- Article
Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 23, p. 3736, doi. 10.3390/cells11233736
- By:
- Publication type:
- Article
Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 7, p. 1694, doi. 10.3390/cells10071694
- By:
- Publication type:
- Article
Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases.
- Published in:
- Human Molecular Genetics, 2008, v. 17, n. 3, p. 431, doi. 10.1093/hmg/ddm320
- By:
- Publication type:
- Article
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
- Published in:
- Human Molecular Genetics, 2005, v. 14, n. 24, p. 3885, doi. 10.1093/hmg/ddi413
- By:
- Publication type:
- Article
Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
- Published in:
- Human Molecular Genetics, 2005, v. 14, n. 17, p. 2571, doi. 10.1093/hmg/ddi292
- By:
- Publication type:
- Article
Sulfhydration mediates neuroprotective actions of parkin.
- Published in:
- Nature Communications, 2013, v. 4, n. 3, p. 1626, doi. 10.1038/ncomms2623
- By:
- Publication type:
- Article
PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 604, p. 1, doi. 10.1126/scitranslmed.aax8891
- By:
- Publication type:
- Article
Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 569, p. 1, doi. 10.1126/scitranslmed.aax0091
- By:
- Publication type:
- Article
Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01180-z
- By:
- Publication type:
- Article
A novel extended form of alpha-synuclein 3′UTR in the human brain.
- Published in:
- Molecular Brain, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13041-018-0371-x
- By:
- Publication type:
- Article
α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
- Published in:
- Molecular Neurodegeneration, 2018, v. 12, p. 1, doi. 10.1186/s13024-017-0233-5
- By:
- Publication type:
- Article
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0538-9
- By:
- Publication type:
- Article
Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death.
- Published in:
- Journal of Neuroscience, 2005, v. 25, n. 35, p. 7968, doi. 10.1523/JNEUROSCI.2172-05.2005
- By:
- Publication type:
- Article
Reduction of Operating Current by Harnessing the Field‐ and Damping‐Like Torque Ratios in Nonmagnet–Ferromagnet Heterojunctions.
- Published in:
- Small Science, 2024, v. 4, n. 2, p. 1, doi. 10.1002/smsc.202300224
- By:
- Publication type:
- Article
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.
- Published in:
- Nature Medicine, 2010, v. 16, n. 9, p. 998, doi. 10.1038/nm.2199
- By:
- Publication type:
- Article
Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss.
- Published in:
- Nature Neuroscience, 2013, v. 16, n. 10, p. 1392, doi. 10.1038/nn.3500
- By:
- Publication type:
- Article
The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model.
- Published in:
- Human Molecular Genetics, 2018, v. 27, n. 13, p. 2344, doi. 10.1093/hmg/ddy143
- By:
- Publication type:
- Article
Nano‐Ligands: Independent Tuning of Nano‐Ligand Frequency and Sequences Regulates the Adhesion and Differentiation of Stem Cells (Adv. Mater. 40/2020).
- Published in:
- Advanced Materials, 2020, v. 32, n. 40, p. 1, doi. 10.1002/adma.202070299
- By:
- Publication type:
- Article
Independent Tuning of Nano‐Ligand Frequency and Sequences Regulates the Adhesion and Differentiation of Stem Cells.
- Published in:
- Advanced Materials, 2020, v. 32, n. 40, p. 1, doi. 10.1002/adma.202004300
- By:
- Publication type:
- Article
Lysosomal Enzyme Glucocerebrosidase Protects against Aβ<sub>1-42</sub> Oligomer-Induced Neurotoxicity.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143854
- By:
- Publication type:
- Article
Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains
- Published in:
- FEBS Letters, 2004, v. 566, n. 1-3, p. 110, doi. 10.1016/j.febslet.2004.04.031
- By:
- Publication type:
- Article